期刊文献+

不同化疗方案在局部晚期宫颈癌患者治疗中的应用效果对比 被引量:8

Comparison of Different Chemotherapy Regimens in the Treatment of Patients with Locally Advanced Cervical Cancer
下载PDF
导出
摘要 目的研究不同化疗方案在局部晚期宫颈癌患者治疗中的应用效果。方法选择局部晚期宫颈癌患者100例,采用随机数表法将所有患者分为观察组和对照组,各50例。观察组采用顺铂联合紫杉醇进行化疗,对照组采用5-氟尿嘧啶联合顺铂进行化疗,以21天作为1个疗程。比较2组患者的临床疗效以及化疗后的不良反应情况。结果 2组患者相比,观察组术中出血量、手术时间和阴道切缘阳性率明显低于对照组,差异有统计学意义(P<0.05)。观察组的客观缓解率高达68.0%,显著高于对照组,差异有统计学意义(P<0.05)。观察组化疗不良反应集中在Ⅰ度、Ⅱ度,明显轻于对照组,差异有统计学意义(P<0.05)。结论采用顺铂联合紫杉醇进行化疗,临床效果较好,且患者的不良反应较轻,值得在临床上推广。 Objective To study the effect of different chemotherapy regimens in the treatment of locally advanced cervi -cal cancer .Methods 100 patients with locally advanced cervical cancer were randomly divided into the observation group and the control group.All patients were treated with cisplatin and paclitaxel for 50 cases.The control group was treated with 5-fluorou-racil and cisplatin chemotherapy ,21 days as a course of treatment ,clinical efficacy and adverse reactions after chemotherapy of the 2 groups were compared .Results Compared with the control group ,the difference between the 2 groups was statistically signifi-cant(P〈0.05).The objective response rate of the observation group was as high as that of the control group (P〈0.05).The in-cidence of adverse reactions in the observation group was significantly lower than that of the control group (P〈0.05).Conclu-sion Cisplatin combined with paclitaxel chemotherapy is effective ,with mild adverse reactions ,it is worthy of clinical promotion .
出处 《实用癌症杂志》 2017年第3期464-465,468,共3页 The Practical Journal of Cancer
关键词 不同化疗方案 局部晚期宫颈癌 应用效果 Different chemotherapy regimens Locally advanced cervical cancer Clinical effect
  • 相关文献

参考文献8

二级参考文献64

  • 1陈涛利,卞翠翠,杨雷,刘子玲.早期高危宫颈癌患者术后不同治疗方案的临床疗效[J].中国老年学杂志,2015,35(1):55-57. 被引量:25
  • 2程晓东,吕卫国,叶枫,陈怀增,谢幸.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006,41(2):95-98. 被引量:66
  • 3王敏,陈桂林,黄燕玲.局部晚期宫颈癌新辅助化疗的近期疗效分析[J].实用肿瘤学杂志,2007,21(4):368-369. 被引量:3
  • 4Rutledge TL, Kamelle SA, Tillmanns TD, et al. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy: Is size the real difference? Gynecol Oncol, 2004,95:70-76.
  • 5Havrilesky LJ, Leath CA , Huh W, et al. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. Gynecol Oneol, 2004, 93:429-434.
  • 6Park DC, Kim JH, Lew YO, et al. Phase II trial of neoadjuvant paelitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol, 2004, 92:59-63.
  • 7Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Eneiso A, et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol, 2003, 14:1278-1284.
  • 8Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemo- therapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: Results from the Italian multicenter randomized study. J Clin Oncol, 2002, 20:179-188.
  • 9Behtash N, Nazari Z, Ayatollahi H, et al. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-II A cervical cancer. Eur J Surg Oncol, 2006, 32:1226-1230.
  • 10Eddy GL, Bundy BN, Creasman WT, et al. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol, 2007, 106:362-369.

共引文献202

同被引文献89

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部